NEW DELHI: Bharat Biotech on Saturday defended its COVID-19 vaccine, Covaxin, terming it safe and efficacious after Haryana Home Minister Anil Vij tested positive for the viral disease despite taking the first shot of the medication.
Vij had offered to be the first volunteer in the phase three trials for Covaxin, an indigenous potential vaccine against COVID-19 being developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR).
The drug firm said its vaccine Covaxin is based on two dose schedule and its efficacy is determined 14 days post the second dosage.
“COVAXIN clinical trials are based on a 2-dose schedule, given 28 days apart. The vaccine efficacy will be determined 14 days post the second dose,” Bharat Biotech said in a statement. (AGENCIES)